Vascular leakage stimulates phenotype alteration in ocular cells, contributing to the pathology of proliferative vitreoretinopathy

Medical Hypotheses

Volumn 50, Issue 2, 1998, Pages 113-117

  Shiels, I A ^b   Zhang, S ^b   Ambler, J ^a   Taylor, S M ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MEMBRANE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD EYE BARRIER; DIABETES MELLITUS; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA EDEMA; VITREORETINOPATHY;

EID: 0031886429     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90195-5     Document Type: Article

References (60)

1. Javitt J C, Canner J K, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989; 96: 255-264.
2. Hayes J P, Lotvall J O, Barnes P J, Newman T A, Chung K F. Involvement of inflammatory mediators in the airway responses to trimellitic anhydride in sensitized guinea-pigs. Br J Pharmacol 1992; 106: 828-832.
3. Chung K F, Barnes P J. Role of inflammatory mediators in asthma. Br Med Bull 1992; 48: 135-148.
4. Ohrui T, Sekizawa K, Aikawa T, Yamauchi K, Sasaki H, Takishima T. Vascular permeability and airway narrowing during late asthmatic response in dogs treated with Metopirone. J Allergy Clin Immunol 1992; 89: 933-943.
5. Campbell G R, Campbell J H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985; 42: 139-162.
6. Joyner W L, Mayhan W G, Johnson R L, Phares C K. Microvascular alterations develop in Syrian hamsters after the induction of diabetes mellitus by streptozotocin. Diabetes 1981; 30: 93-100.
7. Arm J P, Lee T H. The pathobiology of bronchial asthma. Adv Immunol 1992; 51: 323-382.
8. Gabrielian K, Osusky R, Sippy B D, Ryan S J, Hinton D R. Effect of TGF-beta on interferon-gamma-induced HLA-DR expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1994; 35: 4253-4259.
9. Kullberg C E, Arnqvist H J. Good blood glucose control characterizes patients without retinopathy after long diabetes duration. Diabet Med 1995; 12: 314-320.
10. Kullberg C E, Finnstrom K, Arnqvist H J. Severity of background retinopathy in type 1 diabetes increases with the level of long-term glycated haemoglobin. Acta Ophthalmol Copenh 1994; 72: 181-188.
11. Valsania P, Warram J H, Rand L I, Krolewski A S. Different determinants of neovascularization on the optic disc and on the retina in patients with severe nonproliferative diabetic retinopathy. Arch Ophthalmol 1993; 111: 202-206.
12. Stodtler M, Mietz H, Wiedemann P, Heimann K. Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases. Int Ophthalmol 1994; 18: 323-328.
13. Grisanti S, Heimann K, Wiedemann P. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. Br J Ophthalmol 1993; 77: 238-242.
14. Heidenkummer H P, Kampik A. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases]. Fortschr Ophthalmol 1991; 88: 219-224.
15. Campbell J H, Tachas G, Black M J, Cockerill G, Campbell G R. Molecular biology of vascular hypertrophy. Basic Res Cardiol 1991; 1: 3-11.
16. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D study. Am Rev Respir Dis 1993; 148: 720-726.
17. Page C P, Coyle A J. The interaction between PAF, platelets and eosinophils in bronchial asthma. Eur Respir J Suppl 1989; 483S-487S .
18. Weller M, Wiedemann P, Bresgen M, Heimann K. Vitronectin and proliferative intraocular disorders, II: Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes. Int Ophthalmol 1991; 15: 103-108 .
19. Baudouin C, Fredj R D, Jambou D, Gastaud P, Lapalus P. HLA DR and DQ expression on human retinal pigment epithelial cells in vitro. Graefes Arch Clin Exp Ophthalmol 1990; 228: 86-89.
20. Alipui C, Ramos K, Tenner T J. Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus. Cardiovasc Res 1993; 27: 1229-1232.
21. Brewster C E, Howarth P H, Djukanovic R, Wilson J, Holgate S T, Roche W R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3: 507-511.
22. Lutty G A, Merges C, Crone S, McLeod D S. Immunohistochemical insights into sickle cell retinopathy. Curr Eye Res 1994; 13: 125-138.
23. Hayward J M, Noble B A, George N. Secondary intraocular lens implantation: eight year experience. Eye 1990; 4: 548-556.
24. Constable I J, Walker L N, McAllister I L. Subretinal new vessel recurrence in age-related macular degeneration. Aust NZ J Ophthalmol 1989; 17: 273-276.
25. Hui Y N, Wu Y Q, Xiao Q S, Kirchhof B, Heimann K. Repair of outer blood-retinal barrier after severe ocular blunt trauma in rabbits. Graefes Arch Clin Exp Ophthalmol 1993; 231: 365-369.
26. Scheiffarth O F, Kampik A, Gunther H, von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch Clin Exp Ophthalmol 1988; 226: 357-361.
27. Vinores S A, Amin A, Derevjanik N L, Green W R, Campochiaro P A. Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema. Histochem J 1994; 26: 655-665.
28. Lopez P F, Lambert H M, Grossniklaus H E, Sternberg P J. Well defined subfoveal choroidal neovascular membranes in age-related macular degeneration. Ophthalmology 1993; 100: 415-422.
29. Vinores S A, Van N E, Swerdloff J L, Campochiaro P A. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium. Histochem J 1993; 25: 648-663.
30. Atkinson E G, Jones S, Ellis B A, Dumonde D C, Graham E. Molecular size of retinal vascular leakage determined by FITC-dextran angiography in patients with posterior uveitis. Eye 1991; 5: 440-446.
31. Campochiaro P A, Jerdan J A, Glaser B M. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol 1984; 102: 1830-1833.
32. Wallow I H, Greaser M L, Stevens T S. Actin filaments in diabetic fibrovascular preretinal membrane. Arch Ophthalmol 1981; 99: 2175-2181.
33. Walshe R, Esser P, Wiedemann P, Heimann K. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol 1992; 76: 550-552.
34. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995; 36: 391-405.
35. Anderson D H, Johnson L V, Hageman G S. Vitronectin receptor expression and distribution at the photoreceptor-retinal pigment epithelial interface. J Comp Neurol 1995; 360: 1-16.
36. Roth T, Podesta F, Stepp M A, Boeri D, Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA 1993; 90: 9640-9644.
37. Sanders M. Molecular and cellular concepts in atherosclerosis. Pharmacol Ther 1994; 61: 109-153.
38. Halayko A J, Stephens N L. Potential role for phenotypic modulation of bronchial smooth muscle cells in chronic asthma. Can J Physiol Pharmacol 1994; 72: 1448-1457.
39. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 1988; 82: 735-738.
40. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102-110.
41. Sarioglu Y, Utkan T, Utkan N Z, Bozkurt A. Effect of chronic experimental diabetes on vascular smooth muscle function in dog femoral artery. Methods Find Exp Clin Pharmacol 1993; 15: 161-167.
42. Shiels I, Bowler S, Taylor S. Homologous serum increases fibronectin expression and cell adhesion in airway smooth muscle cells. Inflammation 1996; 20: 373-387.
43. McKay B S, Burke J M. Separation of phenotypically distinct subpopulations of cultured human retinal pigment epithelial cells. Exp Cell Res 1994; 213: 85-92.
44. Haley J E, Flood M T, Gouras P, Kjeldbye H M. Proteins from human retinal pigment epithelial cells: evidence that a major protein is actin. Invest Ophthalmol Vis Sci 1983; 24: 803-811.
45. Korte G E, Mrowiec E, Landzberg K S, Youssri A. Reorganization of actin microfilaments and microtubules in regenerating retinal pigment epithelium. Exp Eye Res 1995; 61: 189-203.
46. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995; 36: 391-405.
47. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995; 36: 391-405.
48. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87: 404-408.
49. Raymond M C, Thompson J T. RPE-mediated collagen gel contraction: inhibition by colchicine and stimulation by TGF-beta. Invest Ophthalmol Vis Sci 1990; 31: 1079-1086.
50. Williams D F, Burke J M. Modulation of growth in retinaderived cells by extracellular matrices. Invest Ophthalmol Vis Sci 1990; 31: 1717-1723.
51. Mahalak S M, Lin W L, Essner E, Shichi H. Increased immunoreactivity of collagen types I, III and V, fibronectin and TGF-beta in retinal vessels of rats with experimental autoimmune uveoretinitis. Curr Eye Res 1991; 10: 1059-1063.
52. Campochiaro P A, Glaser B M. Mechanisms involved in retinal pigment epithelial cell chemotaxis. Arch Ophthalmol 1986; 104: 277-280.
53. Grisanti S, Heimann K, Wiedemann P. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. Br J Ophthalmol 1993; 77: 238-242.
54. Heinze J. Advances in vitreoretinal surgery. Modern Med Austr 1994: 66-72.
55. Friberg T R, Eller A W. Pneumatic repair of primary and secondary retinal detachments using a binocular indirect ophthalmoscope laser delivery system. Ophthalmology 1988; 95: 187-193.
56. Stanford M R, Atkinson E, Kasp E, Dumonde D C. Modulation of experimental retinal vasculitis using dexamethasone, cyclosporin A, and prazosin. Eye 1987; 1: 626-631.
57. Kirmani M, Santana M, Sorgente N, Wiedemann P, Ryan S J. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy. Retina 1983; 3: 269-272.
58. Pinon R M, Pastor J C, Saornil M A et al. Intravitreal and subretinal proliferation induced by platelet-rich plasma injection in rabbits. Curr Eye Res 1992; 11: 1047-1055.
59. Yang C H, Huang T F, Liu K R, Chen M S, Hung P T. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Invest Ophthalmol Vis Sci 1996; 37: 843-854.
60. Wagner M, Benson M T, Rennie I G, MacNeil S. Effects of pharmacological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins. Curr Eye Res 1995; 14: 373-384.